Chiropractors in Port Byron, IL Accepting Medicare
4 Chiropractors found. Showing 1 - 4
 Dr. Peter D Crocker, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 106 N High St, Port Byron, IL 61275 Phone: 309-848-9017 Fax: 888-830-9748 |
 River City Alternative Health, Inc. Chiropractor Medicare: Medicare Enrolled Practice Location: 106 N High St, Port Byron, IL 61275 Phone: 309-848-9017 Fax: 888-830-9748 |
Dr. David Lee Bull, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 1010 Rose Hill Rd, Port Byron, IL 61275 Phone: 309-523-3491 Fax: 309-523-3670 |
Bull Clinic P.c. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1010 Rosehill Rd, Port Byron, IL 61275 Phone: 309-523-3491 Fax: 309-523-3670 |
News Archive
Small businesses wary of health care legislation
"Rising costs and a weak economy" are leaving small business employees "with higher out-of-pocket health costs," USA Today reports. Those small companies are "exactly what the non-partisan Congressional Budget Office (CBO) had in mind this month when it estimated as many as 15 million people could lose the benefits they currently receive through their jobs under a Democratic proposal to overhaul health care.
Study describes two new genes that influence risk of women developing breast, ovarian cancer
Today we know that women carrying BCRA1 and BCRA2 gene mutations have a 43% to 88% risk of developing from breast cancer before the age of 70.
DFG is establishing 10 new Collaborative Research Centers to support top-level research in Germany
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is establishing ten new Collaborative Research Centers (CRCs) to further support top-level research in Germany.
Precision-guided anticancer nanoparticles help enhance treatment of peritoneal tumors
Research carried out at the University of Tartu Faculty of Medicine used nanoparticles for the development of new imaging and treatment methods for peritoneal cancers. Tests showed that precision-guided anticancer nanoparticles have improved efficacy and reduced side effects.
Roche, CapitalBio to initiate strategic partnership for molecular diagnostic applications
Roche Diagnostics and CapitalBio have announced their intention to initiate a strategic partnership targeting molecular diagnostic applications and the development of technologies to fill the unmet needs of researchers worldwide. This new development builds on the genomics and diagnostics expertise of the two companies and will focus on furthering microarray technologies and complementary products for molecular diagnostic applications.
› Verified 4 days ago